Sudips Revised Thesis

Total Page:16

File Type:pdf, Size:1020Kb

Sudips Revised Thesis Investigation Of The Behavior Of The Gal4 Inhibitor Gal80 Of The GAL Genetic Switch In The Yeast Saccharomyces Cerevisiae Dissertation Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Sudip Goswami, M.S. Graduate Program in Molecular Genetics The Ohio State University 2014 Dissertation Committee Dr. James Hopper, Advisor Dr. Stephen Osmani Dr. Hay-Oak Park Dr. Jian-Qiu Wu ii Copyright by Sudip Goswami 2014 iii ABSTRACT The DNA-binding transcriptional activator Gal4 and its regulators Gal80 and Gal3 constitute a galactose-responsive switch for the GAL genes of Saccharomyces cerevisiae. Gal4 binds to upstream activation sequences or UASGAL sites on GAL gene promoters as a dimer both in the absence and presence of galactose. In the absence of galactose, a Gal80 dimer binds to and masKs the Gal4 activation domain, inhibiting its activity. In the presence of galactose, Gal3 interacts with Gal80 and relieves Gal80’s inhibition of Gal4 activity allowing rapid induction of expression of GAL genes. In the first part of this work (Chapter 2) in-vitro chemical crosslinking coupled with SDS PAGE and native PAGE analysis were employed to show that the presence of Gal3 that can interact with Gal80 impairs Gal80 self association. In addition, live cell spinning disK confocal imaging showed that dissipation of newly discovered Gal80-2mYFP/2GFP clusters in galactose is dependent on Gal3’s ability to interact with Gal80. In the second part (Chapter 3), extensive analysis of Gal80 clusters was carried out which showed that these clusters associate strongly with the GAL1-10-7 locus and this association is dependent on the presence of the UASGAL sites at this locus. Moreover, the formation of Gal80 clusters is dependent on the presence of Gal4. Additionally, it was discovered that Gal4-2GFP/2mYFP maKes intranuclear foci, which unlike Gal80-2mYFP/2GFP clusters do not dissipate in galactose and their formation is not dependent on the presence of Gal80. Similar to Gal80 clusters, these Gal4 foci associate strongly with the GAL1-10-7 locus. These evidences suggest that large molecular assemblies of Gal80 and Gal4 associate with the UASGAL sites of the GAL1-10-7 locus, which raises some interesting possibilities as to how this genetic switch is regulated. ii I dedicate this work to the “Future” iii Acknowledgements: I would liKe to thanK Prof. James Hopper, my thesis advisor, for his continuous guidance and advice. I would also like to thanK my advisory committee members Prof. Stephen Osmani, Prof. Hay-Oak Park and Prof. Jian-Qiu Wu for their critical and important input into my worK. I thanK all my present J. Hopper lab members, Eric Jiang, Alexander DiScenna and Pallavi Chandna for their technical assistance. I also acknowledge the technical assistance I received from former lab members Kathleen Dotts, Emily Baas, Jill Steinbrunner, Caitlin Rigsby, and others. I would also like to thanK former graduate student Dr. Onur Egriboz with whom I collaborated quite a bit and also for his ideas and input to my worK, former post docs Dr. Xiarong Tao and Dr. Fenglei Jiang for their help, and former lab mate Jin Shuo with whom I did my first project in the lab. I also acKnowledge many students and post docs of other labs for their generous help and cooperation. I am also grateful to Eric Jiang of the Jim Hopper lab and Joey Marquadt of the Harold FisK lab for their critical reading of this thesis. iv Vita 1995 ……………………………………………………...B.S. Pharmaceutical Technology Jadavpur University Kolkata, West Bengal, India 2007………………………………………………………M.S. Biotechnology West Bengal University of Technology Kolkata, West Bengal, India 2007-2014……………………………………………..Graduate Associate, Department of Molecular Genetics The Ohio State University Publication Egriboz O, Goswami S, Tao X, Dotts K, Schaeffer C, Pilauri V, Hopper JE. 2013 Self- association of the Gal4 inhibitor protein Gal80 is impaired by Gal3: evidence for a new mechanism in the GAL gene switch Mol Cell Biol. Sep;33(18):3667-7 Field of Study Major Field: Molecular Genetics v Table of contents Abstract ................................................................................................................................ ii Dedication ........................................................................................................................... iii AcKnowledgement ........................................................................................................... iv Vita ......................................................................................................................................... v Table of Contents ............................................................................................................. vi List of Figures .................................................................................................................... xii List of Tables ...................................................................................................................... xv List of Abbreviations ...................................................................................................... xvii Chapter 1 Regulation of Transcription and The GAL genetic switch .............................. 1 1.Introduction ................................................................................................................... 2 1.2. Main Factors In Transcription Regulation ................................................... 3 1.2.1Core promoter elements ...................................................................... 4 1.2.2 Basal Transcription factors ............................................................... 4 vi 1.2.3Enhancers ................................................................................................... 4 1.2.3.1 Action at a distance-DNA looping ................................ 5 1.2.4 Activators ................................................................................................................. 11 1.3 Genetic regulatory network of yeast galactose pathway ........................ 15 1.3.1 Enzymes for galactose utilization .................................................................. 16 1.3.2 Gal4 – the transcriptional activator .............................................................. 17 1.3.3 Gal80 – the transcriptional inhibitor ........................................................... 21 1.3.4 Gal3 – the galactose sensor and signal transducer ................................ 23 1.3.5 The current model of GAL gene switch ....................................................... 23 2. Chapter 2: Interaction of Gal3 with Gal80 impairs Gal80 self-association ................................................................................................................................................. 27 2.1 Abstract ........................................................................................................................ 28 2.2 Introduction ................................................................................................................ 29 2.3 Materials and Methods .......................................................................................... 31 2.3.1 Yeast strains and plasmids ............................................................................... 31 2.3.2 Microscopy .............................................................................................................. 32 2.3.3 Protein expression and purification ............................................................. 33 2.3.4 Cross-linking of Gal80 and Gal3 ..................................................................... 34 vii 2.3.5 Discontinuous blue native protein gel electrophoresis ....................... 34 2.4 Results ........................................................................................................................... 35 2.4.1 Gal80-Gal80 self-association is impaired under conditions supporting Gal3-Gal80 interaction .......................................................................... 35 2.4.2 The nuclei of live cells display clusters of Gal80-2mYFP that dissipate in response to galactose-triggered Gal3-Gal80 interaction ................................................................................................................................................. 37 2.4.3 Super repressor Gal80S-2 forms more stable higher order oligomers on native gel compared to WT Gal80 ................................................................................................................................................. 38 2.5 Discussion .................................................................................................................... 39 3. Chapter 3 Investigation Of The Intranuclear Clusters Of Gal80 And Intranuclear Foci of Gal4 ................................................................................................................................................. 51 3.1 Abstract ........................................................................................................................ 52 3.2 Introduction ................................................................................................................ 53 3.3 Materials and Methods .......................................................................................... 54 3.3.1 Yeast strains, plasmids, media and growth condition .........................
Recommended publications
  • Liver Med23 Ablation Improves Glucose and Lipid Metabolism Through Modulating FOXO1 Activity
    Cell Research (2014) 24:1250-1265. npg © 2014 IBCB, SIBS, CAS All rights reserved 1001-0602/14 ORIGINAL ARTICLE www.nature.com/cr Liver Med23 ablation improves glucose and lipid metabolism through modulating FOXO1 activity Yajing Chu1, Leonardo Gómez Rosso1, Ping Huang2, Zhichao Wang1, Yichi Xu3, Xiao Yao1, Menghan Bao1, Jun Yan3, Haiyun Song2, Gang Wang1 1State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chi- nese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China; 2Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yueyang Road, Shang- hai 200031, China; 3CAS-MPG Partner Institute for Computational Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China Mediator complex is a molecular hub integrating signaling, transcription factors, and RNA polymerase II (RNAPII) machinery. Mediator MED23 is involved in adipogenesis and smooth muscle cell differentiation, suggesting its role in energy homeostasis. Here, through the generation and analysis of a liver-specific Med23-knockout mouse, we found that liver Med23 deletion improved glucose and lipid metabolism, as well as insulin responsiveness, and prevented diet-induced obesity. Remarkably, acute hepatic Med23 knockdown in db/db mice significantly improved the lipid profile and glucose tolerance. Mechanistically, MED23 participates in gluconeogenesis and cholesterol synthesis through modulating the transcriptional activity of FOXO1, a key metabolic transcription factor. Indeed, hepatic Med23 deletion impaired the Mediator and RNAPII recruitment and attenuated the expression of FOXO1 target genes. Moreover, this functional interaction between FOXO1 and MED23 is evolutionarily conserved, as the in vivo activities of dFOXO in larval fat body and in adult wing can be partially blocked by Med23 knockdown in Drosophila.
    [Show full text]
  • Transcriptional Units
    Proc. Natl. Acad. Sci. USA Vol. 76, No. 7, pp. 3194-3197, July 1979 Biochemistry Cyclic AMP as a modulator of polarity in polycistronic transcriptional units (positive regulation/rho factor/lactose and galactose operons/catabolite repression) AGNES ULLMANNt, EVELYNE JOSEPHt, AND ANTOINE DANCHINt tUnite de Biochimie Cellulaire, Institut Pasteur, 75724 Paris Cedex 15, France; and tInstitut de Biologie Physico-Chimique, 75005 Paris, France Communicated by Frangois Jacob, April 16, 1979 ABSTRACT The degree of natural polarity in the lactose scribed by Watekam et al. (7, 8) in sonicated bacterial extracts. and galactose operons of Escherichia coli is affected by aden- One unit is the amount of enzyme that converts 1 nmol of osine 3',5'-cyclic monophosphate (cAMP). This effect, mediated substrate per min at 280C (except for UDPGal epimerase, for by the cAMP receptor protein, is exerted at sites distinct from the promoter. Experiments performed with a mutant bearing which the assay temperature was 220C). a thermosensitive rho factor activity indicate that cAMP relieves Reagents and Enzymes. They were obtained from the fol- polarity by interfering with transcription termination. Con- lowing companies: trimethoprim from Calbiochem; all radio- flicting results in the literature concerning the role of cAMP active products from Amersham; isopropyl-f3-D-thiogalactoside receptor protein and cAMP in galactose operon expression can (IPTG), D-fucose, cAMP, UDPglucose dehydrogenase, and all be reconciled by the finding that cAMP stimulates the expres- substrates from Sigma; and all other chemicals from Merck. sion of operator distal genes without significantly affecting the proximal genes. Therefore, it appears necessary to reevaluate the classification o(the galactose operon as exhibiting cAMP- RESULTS mediated catabolite repression at the level of transcription Natural Polarity in Lactose Operon.
    [Show full text]
  • Yeast Genome Gazetteer P35-65
    gazetteer Metabolism 35 tRNA modification mitochondrial transport amino-acid metabolism other tRNA-transcription activities vesicular transport (Golgi network, etc.) nitrogen and sulphur metabolism mRNA synthesis peroxisomal transport nucleotide metabolism mRNA processing (splicing) vacuolar transport phosphate metabolism mRNA processing (5’-end, 3’-end processing extracellular transport carbohydrate metabolism and mRNA degradation) cellular import lipid, fatty-acid and sterol metabolism other mRNA-transcription activities other intracellular-transport activities biosynthesis of vitamins, cofactors and RNA transport prosthetic groups other transcription activities Cellular organization and biogenesis 54 ionic homeostasis organization and biogenesis of cell wall and Protein synthesis 48 plasma membrane Energy 40 ribosomal proteins organization and biogenesis of glycolysis translation (initiation,elongation and cytoskeleton gluconeogenesis termination) organization and biogenesis of endoplasmic pentose-phosphate pathway translational control reticulum and Golgi tricarboxylic-acid pathway tRNA synthetases organization and biogenesis of chromosome respiration other protein-synthesis activities structure fermentation mitochondrial organization and biogenesis metabolism of energy reserves (glycogen Protein destination 49 peroxisomal organization and biogenesis and trehalose) protein folding and stabilization endosomal organization and biogenesis other energy-generation activities protein targeting, sorting and translocation vacuolar and lysosomal
    [Show full text]
  • Commentary a Positive Addition to a Negative Tail's Tale Arno L
    Commentary A positive addition to a negative tail's tale Arno L. Greenleaf Biochemistry Department, Duke University Medical Center, Durham, NC 27710 The C-terminal repeat domain (CTD) of threonine hyperphosphorylation, this promoter-proximal paused complexes, the largest subunit ofRNA polymerase II modification produces a shift in SDS/gel thereby allowing productive elongation. is composed of multiple repeats of the mobility. In contrast to c-Abl, a different The presence of CTD kinase activity in consensus heptamer sequence Tyr-Ser- tyrosine kinase, c-Src, does not phos- preinitiation complexes and the apparent Pro-Thr-Ser-Pro-Ser (YSPTSPS in sin- phorylate the CTD in vitro. This addi- association of CTD kinase activity with gle-letter code) (for reviews, see refs. tional information forces a significant re- transcription factor TFIIH are consistent 1-3); thus five of the seven residues of evaluation of our ideas about CTD phos- with this suggestion (refs. 8-10 and the each repeat are potential sites of phos- phorylation. references therein). More recent in vivo phorylation. Indeed, hyperphosphoryla- One obvious question raised by these experiments are also in general agree- tion ofthis domain has been documented findings concerns the identity of the ty- ment with this overall picture (11). It in organisms from yeast to human (one rosine kinase(s) that phosphorylates the should be pointed out, however, that diagnostic for hyperphosphorylation of CTD in vivo. The previously known and despite the identification and character- the CTD is a marked mobility change of now reported properties ofc-Abl are con- ization of a number of different CTD the largest subunit in SDS gels; unphos- sistent with its playing such a role in the kinases, the identity of the kinase(s) act- phorylated subunit "IIa" migrates with nucleus, but additional tests will be re- ing on the CTD in vivo has not been an apparent molecular mass of -215 quired to test critically this possibility.
    [Show full text]
  • Double-Stranded DNA Translocase Activity of Transcription Factor TFIIH and the Mechanism of RNA Polymerase II Open Complex Formation
    Double-stranded DNA translocase activity of transcription factor TFIIH and the mechanism of RNA polymerase II open complex formation James Fishburna, Eric Tomkob, Eric Galburtb,1, and Steven Hahna,1 aDivision of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109; and bDepartment of Biochemistry and Molecular Biophysics, Washington University in St. Louis, St. Louis, MO 63110 Edited by Robert G. Roeder, The Rockefeller University, New York, NY, and approved February 24, 2015 (received for review September 12, 2014) Formation of the RNA polymerase II (Pol II) open complex (OC) re- downstream from the site of DNA unwinding in the OC (20–24). quires DNA unwinding mediated by the transcription factor Therefore, XPB/Ssl2 cannot function as a conventional helicase TFIIH helicase-related subunit XPB/Ssl2. Because XPB/Ssl2 binds to promote OC formation (20). Three models have been pro- DNA downstream from the location of DNA unwinding, it cannot posed to explain the role of XPB/Ssl2 in transcription. First, it function using a conventional helicase mechanism. Here we show was postulated that XPB acts as a molecular wrench, binding to that yeast TFIIH contains an Ssl2-dependent double-stranded DNA its site on downstream DNA and using its ATPase to rotate up- translocase activity. Ssl2 tracks along one DNA strand in the 5′ → stream DNA within the Pol II cleft (20). Because upstream DNA 3′ direction, implying it uses the nontemplate promoter strand to is constrained by TBP, TFIIB, and other factors, DNA rotation reel downstream DNA into the Pol II cleft, creating torsional strain could lead to DNA opening.
    [Show full text]
  • Supplementary Information
    Supplementary Information Table S1. Pathway analysis of the 1246 dwf1-specific differentially expressed genes. Fold Change Fold Change Fold Change Gene ID Description (dwf1/WT) (XL-5/WT) (XL-6/WT) Carbohydrate Metabolism Glycolysis/Gluconeogenesis POPTR_0008s11770.1 Glucose-6-phosphate isomerase −1.7382 0.512146 0.168727 POPTR_0001s47210.1 Fructose-bisphosphate aldolase, class I 1.599591 0.044778 0.18237 POPTR_0011s05190.3 Probable phosphoglycerate mutase −2.11069 −0.34562 −0.9738 POPTR_0012s01140.1 Pyruvate kinase −1.25054 0.074697 −0.16016 POPTR_0016s12760.1 Pyruvate decarboxylase 2.664081 0.021062 0.371969 POPTR_0012s08010.1 Aldehyde dehydrogenase (NAD+) −1.41556 0.479957 −0.21366 POPTR_0014s13710.1 Acetyl-CoA synthetase −1.337 0.154552 −0.26532 POPTR_0017s11660.1 Aldose 1-epimerase 2.770518 0.016874 0.73016 POPTR_0010s11970.1 Phosphoglucomutase −1.25266 −0.35581 0.074064 POPTR_0012s14030.1 Phosphoglucomutase −1.15872 −0.68468 −0.93596 POPTR_0002s10850.1 Phosphoenolpyruvate carboxykinase (ATP) 1.489119 0.967284 0.821559 Citrate cycle (TCA cycle) 2-Oxoglutarate dehydrogenase E2 component POPTR_0014s15280.1 −1.63733 0.076435 0.170827 (dihydrolipoamide succinyltransferase) POPTR_0002s26120.1 Succinyl-CoA synthetase β subunit −1.29244 −0.38517 −0.3497 POPTR_0007s12750.1 Succinate dehydrogenase (ubiquinone) flavoprotein subunit −1.83751 0.519356 0.309149 POPTR_0002s10850.1 Phosphoenolpyruvate carboxykinase (ATP) 1.489119 0.967284 0.821559 Pentose phosphate pathway POPTR_0008s11770.1 Glucose-6-phosphate isomerase −1.7382 0.512146 0.168727 POPTR_0013s00660.1 Glucose-6-phosphate 1-dehydrogenase −1.26949 −0.18314 0.374822 POPTR_0015s00960.1 6-Phosphogluconolactonase 2.022223 0.168877 0.971431 POPTR_0010s11970.1 Phosphoglucomutase −1.25266 −0.35581 0.074064 POPTR_0012s14030.1 Phosphoglucomutase −1.15872 −0.68468 −0.93596 POPTR_0001s47210.1 Fructose-bisphosphate aldolase, class I 1.599591 0.044778 0.18237 S2 Table S1.
    [Show full text]
  • NADP, Corepressor for the Bacillus Catabolite Control Protein Ccpa
    Proc. Natl. Acad. Sci. USA Vol. 95, pp. 9590–9595, August 1998 Microbiology NADP, corepressor for the Bacillus catabolite control protein CcpA JEONG-HO KIM,MARTIN I. VOSKUIL, AND GLENN H. CHAMBLISS* Department of Bacteriology, University of Wisconsin-Madison, E. B. Fred Hall, Madison, WI 53706 Communicated by T. Kent Kirk, University of Wisconsin, Madison, WI, June 10, 1998 (received for review February 12, 1998) ABSTRACT Expression of the a-amylase gene (amyE)of (18), and the presence of a conserved effector-binding domain Bacillus subtilis is subject to CcpA (catabolite control protein in CcpA (3) together strongly suggest the necessity of an A)-mediated catabolite repression, a global regulatory mech- effector(s) such as a corepressor to activate CcpA. To date, anism in Bacillus and other Gram-positive bacteria. To deter- HPr, a phosphocarrier protein in the phosphoenolpyruvate- mine effectors of CcpA, we tested the ability of glycolytic :sugar phosphotransferase system, and two glycolytic metab- metabolites, nucleotides, and cofactors to affect CcpA binding olites, fructose-1,6-diphosphate (FDP) and glucose-6- to the amyE operator, amyO. Those that stimulated the phosphate, have been proposed as effectors of CcpA (19–22). DNA-binding affinity of CcpA were tested for their effect on HPr is phosphorylated in two different fashions: ATP- transcription. HPr-P (Ser-46), proposed as an effector of dependent phosphorylation at Ser-46 and phosphoenolpyru- CcpA, also was tested. In DNase I footprint assays, the affinity vate-dependent phosphorylation at His-15 (23). In the ptsH1 of CcpA for amyO was stimulated 2-fold by fructose-1,6- mutant strain, the serine residue at position 46 of HPr is diphosphate (FDP), 1.5-fold by oxidized or reduced forms of replaced with an alanine, which eliminates phosphorylation of NADP, and 10-fold by HPr-P (Ser-46).
    [Show full text]
  • Studies with the Escherichia Coli Galactose Operon Regulatory Region Carrying a Point Mutation That Simultaneously Inactivates T
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector Volume 219, number 1, 189-196 FEB 04899 July 1987 Studies with the Escherichia coli galactose operon regulatory region carrying a point mutation that simultaneously inactivates the two overlapping promoters Interactions with RNA polymerase and the cyclic AMP receptor protein Sreenivasan Ponnambalarn, Annick Spassky* and Stephen Busby Department of Biochemistry, University of Birmingham, PO Box 363, Birmingham B15 2TT, England and *D~partement de Biologie Molbculaire, lnstitut Pasteur, 25 Rue du Dr Roux, 75724 Paris Cedex 15, France Received 22 April 1987 We report in vitro studies of the interactions between purified E. coli RNA polymerase and DNA from the regulatory region of the E. coli galactose operon which carries a point mutation that simultaneously stops transcription initiation at the two normal start points, $1 and $2. In the presence of this point muta- tion, transcription initiates at a third start point 14/15 bp downstream of $1, showing that inactivation of the two normally active promoters, P1 and P2, unmasks a third weaker promoter, P3. Transcription initia- tion in the gal operon is normally regulated by the cyclic AMP receptor protein, CRP, that binds to the gal regulatory region and switches transcription from P2 to PI. With the point mutation, CRP binding swit- ches transcription from P3 to P1, although the formation of transcriptionally competent complexes at P1 is very slow. The results are discussed with respect to the mechanism of transcription activation by the CRP factor and the similarities between the regulatory regions of the galactose and lactose operons.
    [Show full text]
  • Review Galactokinase: Structure, Function and Role in Type II
    CMLS, Cell. Mol. Life Sci. 61 (2004) 2471–2484 1420-682X/04/202471-14 DOI 10.1007/s00018-004-4160-6 CMLS Cellular and Molecular Life Sciences © Birkhäuser Verlag, Basel, 2004 Review Galactokinase: structure, function and role in type II galactosemia H. M. Holden a,*, J. B. Thoden a, D. J. Timson b and R. J. Reece c,* a Department of Biochemistry, University of Wisconsin, Madison, Wisconsin 53706 (USA), Fax: +1 608 262 1319, e-mail: [email protected] b School of Biology and Biochemistry, Queen’s University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, (United Kingdom) c School of Biological Sciences, The University of Manchester, The Michael Smith Building, Oxford Road, Manchester M13 9PT, (United Kingdom), Fax: +44 161 275 5317, e-mail: [email protected] Received 13 April 2004; accepted 7 June 2004 Abstract. The conversion of beta-D-galactose to glucose unnatural sugar 1-phosphates. Additionally, galactoki- 1-phosphate is accomplished by the action of four en- nase-like molecules have been shown to act as sensors for zymes that constitute the Leloir pathway. Galactokinase the intracellular concentration of galactose and, under catalyzes the second step in this pathway, namely the con- suitable conditions, to function as transcriptional regula- version of alpha-D-galactose to galactose 1-phosphate. tors. This review focuses on the recent X-ray crystallo- The enzyme has attracted significant research attention graphic analyses of galactokinase and places the molecu- because of its important metabolic role, the fact that de- lar architecture of this protein in context with the exten- fects in the human enzyme can result in the diseased state sive biochemical data that have accumulated over the last referred to as galactosemia, and most recently for its uti- 40 years regarding this fascinating small molecule ki- lization via ‘directed evolution’ to create new natural and nase.
    [Show full text]
  • The General Transcription Factors of RNA Polymerase II
    Downloaded from genesdev.cshlp.org on October 7, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW The general transcription factors of RNA polymerase II George Orphanides, Thierry Lagrange, and Danny Reinberg 1 Howard Hughes Medical Institute, Department of Biochemistry, Division of Nucleic Acid Enzymology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey 08854-5635 USA Messenger RNA (mRNA) synthesis occurs in distinct unique functions and the observation that they can as- mechanistic phases, beginning with the binding of a semble at a promoter in a specific order in vitro sug- DNA-dependent RNA polymerase to the promoter re- gested that a preinitiation complex must be built in a gion of a gene and culminating in the formation of an stepwise fashion, with the binding of each factor promot- RNA transcript. The initiation of mRNA transcription is ing association of the next. The concept of ordered as- a key stage in the regulation of gene expression. In eu- sembly recently has been challenged, however, with the karyotes, genes encoding mRNAs and certain small nu- discovery that a subset of the GTFs exists in a large com- clear RNAs are transcribed by RNA polymerase II (pol II). plex with pol II and other novel transcription factors. However, early attempts to reproduce mRNA transcrip- The existence of this pol II holoenzyme suggests an al- tion in vitro established that purified pol II alone was not ternative to the paradigm of sequential GTF assembly capable of specific initiation (Roeder 1976; Weil et al. (for review, see Koleske and Young 1995).
    [Show full text]
  • Phosphorylation and Functions of the RNA Polymerase II CTD
    Downloaded from genesdev.cshlp.org on September 30, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Phosphorylation and functions of the RNA polymerase II CTD Hemali P. Phatnani1 and Arno L. Greenleaf2 Department of Biochemistry, Duke University Medical Center, Durham, North Carolina 27710, USA The C-terminal repeat domain (CTD), an unusual exten- important that the heptads be in tandem: Insertion of an sion appended to the C terminus of the largest subunit of Ala residue between heptads is lethal in yeast, whereas RNA polymerase II, serves as a flexible binding scaffold insertion of an Ala between heptad pairs can be tolerated for numerous nuclear factors; which factors bind is de- (Stiller and Cook 2004). While the CTD is indispensable termined by the phosphorylation patterns on the CTD in vivo, it is frequently not required for general transcrip- repeats. Changes in phosphorylation patterns, as poly- tion factor (GTF)-mediated initiation and RNA synthesis merase transcribes a gene, are thought to orchestrate the in vitro (Zehring et al. 1988; Kim and Dahmus 1989; association of different sets of factors with the transcrip- Buratowski and Sharp 1990; Kang and Dahmus 1993; tase and strongly influence functional organization of Akoulitchev et al. 1995). Thus, the CTD does not form the nucleus. In this review we appraise what is known, part of the catalytic essence of RNAPII; rather, it must and what is not known, about patterns of phosphoryla- perform other functions. The nature and variety of these tion on the CTD of RNA polymerases II at the begin- functions are currently being elucidated and are a main ning, the middle, and the end of genes; the proposal that topic of this review.
    [Show full text]
  • Chapter 21 Operons: Fine Control of Bacterial Transcription
    Chapter 21 Operons: Fine Control of Bacterial Transcription The E. coli genome contains over 3000 genes. Some of these are active all the time because their products are in constant demand. But some of them are turned off most of the time because their products are rarely needed. For example, the enzymes required for the metabolism of the sugar arabinose would be useful only when arabinose is present and when the organism’s favorite energy source, glucose, is absent. Such conditions are not common, so the genes encoding these enzymes are usually turned off. Why doesn’t the cell just leave all its genes on all the time, so the right enzymes are always there to take care of any eventuality? The reason is that gene expression is an expensive process. It takes a lot of energy to produce RNA and protein. In fact, if all of an E. coli cell’s genes were turned on all the time, production of RNAs and proteins would drain the cell of so much energy that it could not compete with more effi cient organisms. Thus, control of gene expression is essential to life. Gene regulation is the device to insure that proteins are synthesized in exactly the amounts they are needed and only when they are needed. Transcriptional regulation: gene expression is controlled by regulatory proteins Negative regulation: - A repressor protein inhibits transcription of a specific gene. - In this case, inducer (antagonist of the repressor) is needed to allow transcription. Positive regulation: - Activator works to increase the frequency of transcription of an gene (operon) Transcriptional regulation: gene expression is controlled by regulatory proteins Operons Operons and the resulting transcriptional regulation of gene expression permit prokaryotes to rapidly adapt to changes in the environment: new carbon sources, lack of an amino acid, etc.
    [Show full text]